Changes to the healthcare industry in general, and pharmaceuticals in particular, have affected the values and valuations of pharmacies of all types. So tune in to Valuing Pharmacies,Part 8 of BVR's 2013 Online Symposium on Healthcare Valuation on August 27. Experts James Lloyd and Jeff Milam (both Pershing Yoakley & Associates) will reveal what every appraiser should know about this piece of the healthcare industry valuation puzzle.
How are claims and remedies of unjust enrichment defined, argued, and quantified? What must financial experts know when preparing or presenting such an analysis? The answers will be revealed on September 10, in Unjust Enrichment, Part 7 of BVR's 2013 Online Symposium on Economic Damages, with expert George Roach (George Roach Litigation Consulting).
Despite years of research, regulatory and judicial guidance, and real-world testing, consensus on pass-through entity valuation techniques remains elusive. Still, an effective, reliable, and defensible technique appears close at hand. On September 12 in S Corps … What a Long, Strange Trip It's Been, expert Nancy Fannon (Myers Harrison & Pia) reviews the history of thought in pass-through entity valuation with an eye toward creating a simple solution to this complex problem.
Please let us know
if you have any comments about this article or enhancements you would like to see.